Ginsenoside Rb1, a panoxadiol saponin against oxidative damage and renal interstitial fibrosis in rats with unilateral ureteral obstruction

Chinese Journal of Integrative Medicine

Volumn 15, Issue 2, 2009, Pages 133-140

  Xie, Xi Sheng ^a   Liu, Heng Chuan ^b   Yang, Man ^a   Zuo, Chuan ^a   Deng, Yao ^a   Fan, Jun Ming ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Ginsenoside Rb1; Oxidative stress; p47phox; Transforming growth factor beta1; Unilateral ureteral obstruction

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; COLLAGEN TYPE 1; FIBRONECTIN; GINSENOSIDE RB 1; HEME OXYGENASE 1; LOSARTAN; MESSENGER RNA; PROTEIN P47PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SAPONIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; URETER OBSTRUCTION;

ANIMALS; DEOXYGUANOSINE; DRUG EVALUATION, PRECLINICAL; FIBROSIS; GENE EXPRESSION REGULATION; GINSENOSIDES; HEME OXYGENASE (DECYCLIZING); KIDNEY; KIDNEY DISEASES; MALE; MODELS, BIOLOGICAL; NADPH OXIDASE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 65349164609     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-009-0133-9     Document Type: Article

References (33)

1. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217.
2. Manucha W. Biochemical-molecular markers in unilateral ureteral obstruction. Biocell 2007; 31:1-12.
3. Ha H, Lee HB. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology-(Carlton) 2005;10 Suppl: S7-S10.
4. Hwang M, Kim HJ, Noh HJ, Chang YC, Chae YM, Kim KH, et al. TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol 2006; 81:48-54.
5. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, et al. Role of reactive oxygen species in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005; 16:667-675.
6. Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, et al. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. Nephrol Dial Transplant 2004;19:3012-3020.
7. Sugiyama H, Kobayashi M, Wang DH, Sunami R, Maeshima Y, Yamasaki Y, et al. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol Dial Transplant 2005; 20:2670-2680.
8. Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 2003;14: S221-S226.
9. Moriyama T, Kawada N, Nagatoya K, Takeji M, Horio M, Ando A, et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 2001;59:2095-2103.
10. Saborio P, Krieg RJ Jr, Kuemmerle NB, Norkus EP, Schwartz CC, Chan JC. Alpha-tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy. Pediatr Nephrol 2000;14:740-746.
11. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, et al. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 2005; 16:3631-3641.
12. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, et al. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 2005; 67:1890-1898.
13. Xu QF, Fang XL, Chen DF. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmacol 2003; 84:187-192.
14. Li L, Sheng YX, Zhang JL, Wang SS, Guo DA. High-performance liquid chromatographic assay for the active saponins from Panax notoginseng in rat tissues. Biomed Chromatogr 2006; 20:327-335.
15. Su BH, Li Z, Fan JM, Wang M, Tang R. Effects of panax notoginseng saponins on the process of renal interstitial fibrosis after unilateral ureteral obstruction in rats. J Sichuan Univ (Natural Sci Edit, Chin) 2005; 36:368-371.
16. Wang M, Fan JM, Liu XY. Effect of total saponins of Panax notoginseng on transdifferentiation of rats' tubular epithelial cell induced by IL-1 alpha. Chin J Integr Tradit West Med (Chin) 2004; 24:722-725.
17. Ohashi R, Yan S, Mu H, Chai H, Yao Q, Lin PH, et al. Effects of homocysteine and ginsenoside Rb1 on endothelial proliferation and superoxide anion production. J Surg Res 2006;133:89-94.
18. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 2005; 41:861-868.
19. 2- and OH. Chin Tradit Herbal Drugs (Chin) 1999; 22:303-306.
20. Kang KS, Lee YJ, Park JH, Yokozawa T. The effects of glycine and L-argining on heat stability of ginsenoside Rb1. Biol Pharm Bull 2007;30:1975-1978.
21. Morrissey JJ, Klahr S. Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol 1998; 274:580-586.
22. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, Klahr S. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol 2001; 280:777-785.
23. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994; 45:1637-1647.
24. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995; 47:1285-1294.
25. Mizuguchi Y, Miyajima A, Kosaka T, Asano T, Asano T, Hayakawa M. Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol 2004; 1726:2456-2459.
26. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30: 36.
27. Fu P, Liu F, Su S, Huang XR, Entman ML, Schwartz RJ, et al. Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J Am Soc Nephrol 2006; 17:3105-3114.
28. Kanauchi M, Nishioka H, Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 2002; 91:327-329.
29. Boonla C, Wunsuwan R, Tungsanga K, Tosukhowong P. Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 2007; 35:185-191.
30. Pat B, Yang T, Kong C, Watters D, Johnson DW, Gobe G. Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 2005; 67:931-943.
31. Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 2006;70:1234-1243.
32. Mizuguchi Y, Chen J, Seshan SV, Poppas DP, Szeto HH, Felsen D. A novel cell permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol 2008;295:1545-1553.
33. Manucha W, Oliveros L, Carrizo L, Seltzer A, Vallés P. Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney Int 2004;65:2091-2107.